Literature DB >> 14403478

The successful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin.

G D HOWDEN.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN/therapy; RETINA/blood supply; THROMBOSIS/therapy

Mesh:

Substances:

Year:  1959        PMID: 14403478      PMCID: PMC1831374     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Treatment of thrombosis with fibrinolysin (plasmin).

Authors:  J E SOKAL; J L AMBRUS; C M AMBRUS
Journal:  J Am Med Assoc       Date:  1958-11-08

2.  Thrombolysis with fibrinolysin (plasmin)-new therapeutic approach to thromboembolism.

Authors:  K M MOSER
Journal:  J Am Med Assoc       Date:  1958-08-02
  2 in total
  6 in total

1.  Fibrinolysis in retinal vein occlusions. A preliminary report.

Authors:  R Höhmann; M Martin; E Weigelin
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973

Review 2.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 3.  Photocoagulation in retinal vein occlusion.

Authors:  S C Sedney
Journal:  Doc Ophthalmol       Date:  1976-01-28       Impact factor: 2.379

4.  Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion.

Authors:  M J Elman; R Z Raden; A Carrigan
Journal:  Trans Am Ophthalmol Soc       Date:  2001

5.  Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.

Authors:  M J Elman
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.